RKDA logo

Arcadia Biosciences (RKDA) Cash From Operations

Annual CFO

-$15.29 M
-$1.32 M-9.42%

December 31, 2023

Summary

Performance

1-Year Change

-9.42%

3-Year Change

+49.39%

5-Year Change

-12.2%

15-Year Change

-9.52%

RKDA Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

9.09%
RKDA annual cash flow from operations is higher than 9.09% of companies in Consumer Defensive sector

High & Low

All-time High

-$9.59 M

3-Year Low

-$25.87 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
RKDA previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
RKDA next annual earnings announcement is scheduled for Feb 28, 2025

OtherRKDAcash flowmetrics:

Annual CFI

-$4.34 M
RKDA annual cash flow from investing activities is -$4.34 million

Annual CFF

$5.51 M
RKDA annual cash flow from financing activities is $5.51 million

Annual FCF

-$15.30 M
RKDA annual free cash flow is -$15.30 million

Annual CAPEX

$5000.00
RKDA annual capital expenditures is $5000.00

Quarterly CFO

-$1.75 M
+$704.00 K+28.66%

September 30, 2024

Summary

Performance

3-Month Change

+28.66%

1-Year Change

+39.27%

3-Year Change

+49.45%

5-Year Change

+49.45%

RKDA Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

17.31%
RKDA quarterly cash flow from operations is higher than 17.31% of companies in Consumer Defensive sector

High & Low

All-time High

-$1.75 M
RKDA quarterly cash flow from operations is currently at an all-time high

3-Year Low

-$6.66 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RKDA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
RKDA next earnings announcement is scheduled for Feb 28, 2025

OtherRKDAcash flowmetrics:

Quarterly CFI

$180.00 K
RKDA quarterly cash flow from investing activities is $180.00 thousand

Quarterly CFF

$4000.00
RKDA quarterly cash flow from financing activities is $4000.00

Quarterly FCF

-$1.75 M
RKDA quarterly free cash flow is -$1.75 million

Quarterly CAPEX

$0.00
RKDA quarterly capital expenditures is $0.00

TTM CFO

-$11.56 M
+$1.13 M+8.92%

September 30, 2024

Summary

Performance

3-Month Change

+8.92%

1-Year Change

+14.38%

3-Year Change

+7.92%

5-Year Change

+7.92%

RKDA TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

5.29%
RKDA TTM cash flow from operations is higher than 5.29% of companies in Consumer Defensive sector

High & Low

All-time High

-$2.13 M

3-Year Low

-$26.05 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RKDA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
RKDA next earnings announcement is scheduled for Feb 28, 2025

OtherRKDAcash flowmetrics:

TTM CFI

$4.88 M
RKDA TTM cash flow from investing activities is $4.88 million

TTM CFF

$9000.00
RKDA TTM cash flow from financing activities is $9000.00

TTM FCF

-$11.58 M
RKDA TTM free cash flow is -$11.58 million

TTM CAPEX

$16.00 K
RKDA TTM capital expenditures is $16.00 thousand

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

RKDA Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-9.4%+39.3%+14.4%
3 y3 years+49.4%+49.5%+7.9%
5 y5 years-12.2%+49.5%+7.9%

RKDA Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-9.4%+40.9%at high+73.7%at high+55.6%
5 y5-year-9.4%+49.4%at high+81.1%at high+61.7%
alltimeall time-59.5%+49.4%at high+81.1%-443.9%+61.7%

Arcadia Biosciences Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.75 M(-28.7%)
-$11.56 M(-8.9%)
Jun 2024
-
-$2.46 M(-23.5%)
-$12.70 M(-15.6%)
Mar 2024
-
-$3.21 M(-22.6%)
-$15.04 M(-1.7%)
Dec 2023
-$15.29 M(+9.4%)
-$4.14 M(+43.7%)
-$15.29 M(+13.2%)
Sep 2023
-
-$2.88 M(-39.9%)
-$13.51 M(-3.5%)
Jun 2023
-
-$4.80 M(+38.4%)
-$13.99 M(+11.4%)
Mar 2023
-
-$3.47 M(+47.1%)
-$12.56 M(-10.2%)
Dec 2022
-$13.98 M(-46.0%)
-$2.36 M(-30.1%)
-$13.98 M(-23.5%)
Sep 2022
-
-$3.37 M(+0.2%)
-$18.28 M(-21.1%)
Jun 2022
-
-$3.37 M(-31.1%)
-$23.18 M(-11.0%)
Mar 2022
-
-$4.88 M(-26.7%)
-$26.05 M(+0.7%)
Dec 2021
-$25.87 M(-14.4%)
-$6.66 M(-19.4%)
-$25.87 M(-0.4%)
Sep 2021
-
-$8.27 M(+32.6%)
-$25.96 M(+5.5%)
Jun 2021
-
-$6.23 M(+32.4%)
-$24.61 M(-4.1%)
Mar 2021
-
-$4.71 M(-30.3%)
-$25.66 M(-15.1%)
Dec 2020
-$30.22 M(+75.7%)
-$6.75 M(-2.4%)
-$30.22 M(+6.1%)
Sep 2020
-
-$6.92 M(-4.9%)
-$28.48 M(+12.5%)
Jun 2020
-
-$7.28 M(-21.5%)
-$25.32 M(+12.5%)
Mar 2020
-
-$9.27 M(+85.0%)
-$22.50 M(+30.8%)
Dec 2019
-$17.20 M
-$5.01 M(+33.4%)
-$17.20 M(+15.6%)
Sep 2019
-
-$3.76 M(-15.8%)
-$14.88 M(-1.7%)
Jun 2019
-
-$4.46 M(+12.4%)
-$15.14 M(+1.1%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$3.97 M(+47.3%)
-$14.98 M(+9.9%)
Dec 2018
-$13.63 M(-2.4%)
-$2.69 M(-32.9%)
-$13.63 M(+0.1%)
Sep 2018
-
-$4.02 M(-6.6%)
-$13.62 M(+13.8%)
Jun 2018
-
-$4.30 M(+64.3%)
-$11.97 M(-0.7%)
Mar 2018
-
-$2.62 M(-2.5%)
-$12.05 M(-13.7%)
Dec 2017
-$13.96 M(-18.1%)
-$2.68 M(+13.4%)
-$13.96 M(-10.2%)
Sep 2017
-
-$2.37 M(-46.1%)
-$15.56 M(-9.1%)
Jun 2017
-
-$4.39 M(-3.2%)
-$17.13 M(+2.4%)
Mar 2017
-
-$4.53 M(+5.9%)
-$16.73 M(-1.9%)
Dec 2016
-$17.05 M(+12.9%)
-$4.28 M(+8.8%)
-$17.05 M(+2.0%)
Sep 2016
-
-$3.93 M(-1.5%)
-$16.72 M(-3.7%)
Jun 2016
-
-$3.99 M(-17.8%)
-$17.37 M(+0.0%)
Mar 2016
-
-$4.86 M(+23.0%)
-$17.37 M(+14.9%)
Dec 2015
-$15.11 M(+2.2%)
-$3.95 M(-13.9%)
-$15.11 M(+9.3%)
Sep 2015
-
-$4.58 M(+15.0%)
-$13.82 M(+6.8%)
Jun 2015
-
-$3.98 M(+53.3%)
-$12.95 M(-15.2%)
Mar 2015
-
-$2.60 M(-2.3%)
-$15.26 M(+3.2%)
Dec 2014
-$14.79 M(+51.7%)
-$2.66 M(-28.3%)
-$14.79 M(+21.9%)
Sep 2014
-
-$3.71 M(-41.1%)
-$12.13 M(+44.0%)
Jun 2014
-
-$6.30 M(+196.2%)
-$8.42 M(+296.2%)
Mar 2014
-
-$2.13 M
-$2.13 M
Dec 2013
-$9.74 M(+1.6%)
-
-
Dec 2012
-$9.59 M
-
-

FAQ

  • What is Arcadia Biosciences annual cash flow from operations?
  • What is the all time high annual CFO for Arcadia Biosciences?
  • What is Arcadia Biosciences annual CFO year-on-year change?
  • What is Arcadia Biosciences quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Arcadia Biosciences?
  • What is Arcadia Biosciences quarterly CFO year-on-year change?
  • What is Arcadia Biosciences TTM cash flow from operations?
  • What is the all time high TTM CFO for Arcadia Biosciences?
  • What is Arcadia Biosciences TTM CFO year-on-year change?

What is Arcadia Biosciences annual cash flow from operations?

The current annual CFO of RKDA is -$15.29 M

What is the all time high annual CFO for Arcadia Biosciences?

Arcadia Biosciences all-time high annual cash flow from operations is -$9.59 M

What is Arcadia Biosciences annual CFO year-on-year change?

Over the past year, RKDA annual cash flow from operations has changed by -$1.32 M (-9.42%)

What is Arcadia Biosciences quarterly cash flow from operations?

The current quarterly CFO of RKDA is -$1.75 M

What is the all time high quarterly CFO for Arcadia Biosciences?

Arcadia Biosciences all-time high quarterly cash flow from operations is -$1.75 M

What is Arcadia Biosciences quarterly CFO year-on-year change?

Over the past year, RKDA quarterly cash flow from operations has changed by +$1.13 M (+39.27%)

What is Arcadia Biosciences TTM cash flow from operations?

The current TTM CFO of RKDA is -$11.56 M

What is the all time high TTM CFO for Arcadia Biosciences?

Arcadia Biosciences all-time high TTM cash flow from operations is -$2.13 M

What is Arcadia Biosciences TTM CFO year-on-year change?

Over the past year, RKDA TTM cash flow from operations has changed by +$1.94 M (+14.38%)